.Cognition Therapies' phase 2 sparkle trial has taken several of the appeal off the Alzheimer's ailm...
.Bristol Myers Squibb has had a whiplash change of mind on its own BCMA bispecific T-cell engager, h...
.Charles Baum, M.D., Ph.D., who oversaw Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squibb in...
.After connecting to greater than 200 providers to partner a Tourette syndrome treatment that reveal...
.Novartis has actually had some rotten luck with bispecific antitoxins in the past, however determin...
.Pinetree Rehabs will definitely aid AstraZeneca plant some plants in its pipeline with a brand new ...
.GRO Biosciences has finished the week along with an extra $60.3 thousand in the bank, which the pro...
.Invite to this week's Chutes & Ladders, our summary of significant management hirings, shootings...